Dr Eveline Hürlimann is a senior scientific collaborator at Swiss TPH. Her research interests include integrated control strategies against neglected tropical diseases (mainly diarrheal diseases such as soil-transmitted helminths and schistosomiasis), including WASH, community-directed approaches and combination therapy; clinical research; the optimization of anthelminthic treatment against soil-transmitted helminths and the assessment of the treatment benefits of regular deworming in endemic communities (clinically examined and self-reported) to advocate for more effective helminth control efforts and policy change.

Dr Hürlimann has published more than 40 articles in peer-reviewed literature, including 10 as first author. She has also coordinated a three-year multi-country randomized controlled trial in three developing countries, including the co-supervision of three PhD students, which has led to more than 10 scientific articles that are either published or under review. Her work has contributed to the inclusion of a new indication for the administration of ivermectin on the essential medicines list of the World Health Organization for soil-transmitted helminth control. She was awarded the 2017 Prix CSRS-Fonds Eremitage for scientific research and the 2022 Anne Maurer-Cecchini Award for outstanding clinical or epidemiological research on a neglected tropical disease in 2020 or 2021.